| 000 | 01584 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514184326.0 | ||
| 264 | 0 | _c20040510 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a0014-4886 | ||
| 024 | 7 |
_a10.1016/j.expneurol.2003.12.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSortwell, Caryl E | |
| 245 | 0 | 0 |
_aAn in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality. _h[electronic resource] |
| 260 |
_bExperimental neurology _cMay 2004 |
||
| 300 |
_a58-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmphetamine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain Tissue Transplantation _xmethods |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aCell Survival _xphysiology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine Agents _xpharmacology |
| 650 | 0 | 4 |
_aFetal Tissue Transplantation _xmethods |
| 650 | 0 | 4 |
_aGraft Survival _xphysiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesencephalon _xcytology |
| 650 | 0 | 4 |
_aNeurons _xcytology |
| 650 | 0 | 4 | _aOxidopamine |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xpathology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xbiosynthesis |
| 700 | 1 | _aCollier, Timothy J | |
| 700 | 1 | _aCamargo, Maria D | |
| 700 | 1 | _aPitzer, Mark R | |
| 773 | 0 |
_tExperimental neurology _gvol. 187 _gno. 1 _gp. 58-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2003.12.008 _zAvailable from publisher's website |
| 999 |
_c14795189 _d14795189 |
||